This dashboard provides key metrics and interactive summaries for datasets available in neurodegenerative disease research. The dashboard serves as a quick-reference hub for data availability, quality metrics, and resource connections across genomics, transcriptomics, proteomics, imaging, and clinical domains.
| Category |
Datasets |
Total Samples |
Update Frequency |
| Genomics |
45+ |
50,000+ |
Quarterly |
| Transcriptomics |
30+ |
25,000+ |
Monthly |
| Proteomics |
25+ |
15,000+ |
Monthly |
| Imaging (MRI/PET) |
40+ |
20,000+ |
Continuous |
| Clinical |
60+ |
100,000+ |
Continuous |
| Multi-omics |
15+ |
10,000+ |
Quarterly |
| Metric |
Average |
Best |
| Sample Size |
500+ |
10,000+ |
| Metadata Completeness |
75% |
95% |
| Data Standardization |
65% |
90% |
| Accessibility Score |
70% |
100% |
| Dataset |
Samples |
Modalities |
Access |
| AMP-AD |
2,000+ |
WGS, RNA-seq |
NIAGADS |
| ADNI |
2,500+ |
MRI, PET, CSF |
LONI |
| DIAN |
500+ |
Longitudinal |
DIAN |
| A4 Study |
4,500+ |
Amyloid+ |
LONI |
| ROS/MAP |
1,800+ |
Brain tissue |
Rush |
| Dataset |
Samples |
Modalities |
Access |
| AMP-PD |
10,000+ |
WGS, clinical |
AMP-PD |
| PPMI |
1,800+ |
Clinical, imaging |
LONI |
| PDBP |
1,200+ |
Multiple |
NIH |
| Parkinson's Progression Markers |
1,500+ |
Longitudinal |
PPMI |
| Dataset |
Samples |
Modalities |
Access |
| Target ALS |
1,000+ |
WGS, RNA-seq |
Target ALS |
| ALSGene |
15,000+ |
GWAS |
Project MinE |
| Answer ALS |
1,000+ |
iPSC, genomics |
Answer ALS |
| CNTF ALS |
500+ |
Clinical |
Clinical |
| Dataset |
Citations |
Impact |
| ADNI |
15,000+ |
Highest |
| PPMI |
8,000+ |
Very High |
| AMP-AD |
5,000+ |
Very High |
| ROS/MAP |
4,500+ |
High |
| AMP-PD |
3,500+ |
High |
| Resource |
Annual Downloads |
Users |
| ADNI |
50,000+ |
2,000+ |
| AMP-AD |
35,000+ |
1,500+ |
| PPMI |
30,000+ |
1,200+ |
| Allen Brain Atlas |
25,000+ |
3,000+ |
| Integration Type |
Available |
Tools |
| Genomics + Transcriptomics |
Yes |
SCALLOP-DEP |
| Imaging + Genomics |
Yes |
MindX |
| Proteomics + Metabolomics |
Yes |
AMP-AD |
| Cross-disease Analysis |
Yes |
CommonMind |
| Dataset |
API |
REST |
GraphQL |
| Allen Brain Atlas |
Yes |
Yes |
No |
| ADNI |
Partial |
Limited |
No |
| AMP-PD |
Yes |
Yes |
No |
| PPMI |
Yes |
Yes |
No |
| Disease |
Percentage |
Primary Data Types |
| Alzheimer's |
35% |
Imaging, CSF |
| Parkinson's |
25% |
Clinical, genomics |
| ALS |
15% |
Genomics, iPSC |
| FTD |
10% |
Genomics, imaging |
| Other |
15% |
Mixed |
| Modality |
Percentage |
Growth Rate |
| Genomic |
30% |
15%/year |
| Imaging |
25% |
20%/year |
| Clinical |
20% |
10%/year |
| Proteomic |
15% |
25%/year |
| Transcriptomic |
10% |
18%/year |
Dataset counts and metrics are aggregated from the listed data repositories and resource websites as of March 2025. Accessibility scores reflect ease of data access (open access = 100%, controlled = 50%, application required = 75%). Citations reflect Google Scholar counts as of the same date.